| API | Non pwodwi | KA NON. | Klasifikasyon |
| Kanagliflozin | 2-(4-Fluorophenyl)-5-[(5-yodo-2-methylphenyl)methyl]tiofèn | 898566-17-1 | dyabèt |
| Empagliflozin | (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan | 915095-89-5 | dyabèt |
| Linagliptin | 8-bromo-7-(men-2-inyl)-3-methyl-1H-purine-2,6 (3H,7H)-dyon | 666816-98-4 | dyabèt |
| Linagliptin | 2-(chloromethyl)-4-methylquinazoline | 109113-72-6 | dyabèt |
| Linagliptin | 8-Bromo-7-but-2-inyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl) -3,7-dihydro-purine-2,6-dyon | 853029-57-9 | dyabèt |
| Saxagliptin | (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic asid tert-butyl ester | 361440-67-7 | dyabèt |
| Saxagliptin | (alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytriciklo[3.3.1.13,7]decane-1-acetic asid | 361442-00-4 | dyabèt |
| Sitagliptin | 2,4,5-Trifluorophenylacetic asid | 209995-38-0 | dyabèt |
| Sitagliptin | Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Asid | 486460-00-8 | dyabèt |
| Sitagliptin | 3-(Trifluorometil)-5,6,7,8-tetrahydro-[1,2,4]triazolo [4,3-a]pirazin idroklorid | 762240-92-6 | dyabèt |
| Vildagliptin | L-prolinamid | 7531-52-4 | dyabèt |
| Vildagliptin | (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 207557-35-5 | dyabèt |
| Empagliflozin Dapagliflozin/Canagliflozin | 2,3,4,6-Tetrakis-O-trimethylsilil-D-gluconolactone | 32384-65-9 | dyabèt |
| Vildagliptin | L-prolinamid | 7531-52-4 | dyabèt |
| Liraglutide | Liraglutide | 204656-20-2 | dyabèt |
| ABT-888 | (S)-2-Methylproline | 42856-71-3 | Anti-kansè |
| Docetaksèl | 10-Deacetylbaccatin III | 32981-86-5 | Anti-kansè |
| Lenvatinib | 4-chloro-7-methoxyquinoline-6-carboxamide | 417721-36-9 | Anti-kansè |
| Lenvatinib | 4-Amino-3-chlorophenol idroklorid | 52671-64-4 | Anti-kansè |
| Akalabrutinib | (3-Chloropyrazin-2-yl) MethanaMine hydrochloride | 939412-86-9 | Anti-kansè |
| Akalabrutinib | N-Benzyloxycarbonyl-L-proline | 1148-11-4 | Anti-kansè |
| Akalabrutinib | N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamid | 1383385-64-5 | Anti-kansè |
| Akalabrutinib | 2-Butynoic asid | 590-93-2 | Anti-kansè |
| Nilotinib | 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluorometil)anilin | 641571-11-1 | Anti-kansè |
| Nilotinib | Diphenylphosphoryl azid | 26386-88-9 | Anti-kansè |
| Nilotinib | 4-Methyl-3-[[4-(3-piridinil)-2-pirimidinyl]amino]benzoik asid | 641569-94-0 | Anti-kansè |
| Nilotinib | 1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-yon sèl | 55314-16-4 | Anti-kansè |
| Abiraterone Acetate | 17-Iodoandrosta-5,16-dien-3beta-ol | 32138-69-5 | Anti-kansè |
| Abiraterone Acetate | 17-Iodoandrosta-5,16-dien-3beta-ol 3-acetate | 114611-53-9 | Anti-kansè |
| Neratinib | 3-chloro-4-(piridin-2-ylmethoxy)anilin | 524955-09-7 | Anti-kansè |
| Neratinib | N-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl)acetamid | 848133-76-6 | Anti-kansè |
| Neratinib | 6-amino-4-(3-chloro-4-(piridin-2-ylmethoxy)phenylamino)-7-ethoxyquinoline-3-karbonitrile | 848139-78-6 | Anti-kansè |
| Neratinib | trans-4-dimethylaminocrotonic asid idroklorid | 848133-35-7 | Anti-kansè |
| Palbociclib | tert-butil 4-(6-amino-3-piridil) piperazin-1-carboxylate | 571188-59-5 | Anti-kansè |
| Palbociclib | 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-yon sèl | 1016636-76-2 | Anti-kansè |
| Ribociclib | 2-Chloro-7-cyclopentyl-n,n-dimethyl-7h-pyrrolo[2,3d]pyrimidine-6-carboxamide | 1211443-61-6 | Anti-kansè |
| Ribociclib | 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic asid | 1211443-58-1 | Anti-kansè |
| Ceritinib/Crizotinib | 4-(4-Bromopyrazol-1-yl)piperidine-1-carboxylic asid tert-butil ester | 877399-50-3 | Anti-kansè |
| Ceritinib/Crizotinib | tert-Butil 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pirazol-1-yl]piperidin-1-carboxylate | 877399-74-1 | Anti-kansè |
| Ceritinib/Crizotinib | (S) -1-(2,6-Dichloro-3-fluorophenyl) etanòl | 877397-65-4;42247-74-5 | Anti-kansè |
